First Human Test of CRISPR Proposed
By Antonio Regalado,
MIT Technology Review
| 06. 16. 2016
A federal safety board next week will consider the first human use of the gene-editing technology CRISPR, according to the National Institutes of Health.
The proposed treatment is an immune therapy in which a patient’s own blood cells will be removed and genetically altered using the technology, a type of molecular scissors able to precisely cut DNA.
The cancer treatment, in development by the University of Pennsylvania, is designed to target myeloma, melanoma, and sarcomas, according to the NIH.
Continue reading on MIT Technology Review
Image via Flickr
Related Articles
By Roni Caryn Rabin, The New York Times | 01.22.2026
The National Institutes of Health said on Thursday it is ending support for all research that makes use of human fetal tissue, eliminating funding for projects both within and outside of the agency.
A ban instituted in June 2019 by...
By Mike McIntire, The New York Times | 01.24.2026
Genetic researchers were seeking children for an ambitious, federally funded project to track brain development — a study that they told families could yield invaluable discoveries about DNA’s impact on behavior and disease.
They also promised that the children’s sensitive...
By Phil Galewitz, NPR | 01.20.2026
Serenity Cole enjoyed Christmas last month relaxing with her family near her St. Louis home, making crafts and visiting friends.
It was a contrast to how Cole, 18, spent part of the 2024 holiday season. She was in the hospital...
By Dan Barry and Sonia A. Rao, The New York Times | 01.26.2026
Photo by Gage Skidmore from Peoria, AZ, United States
of America, CC BY-SA 2.0, via Wikimedia Commons
Late last month, a woman posted a photograph on social media of a purple hat she had knitted, while a black-and-white dog...
.jpg){kind=link}